People who require medication for their attention deficit hyperactivity disorder (ADHD) continue to have a difficult time getting their prescriptions filled due to a lack of available medication. The ...

Shire and New River Pharmaceuticals have received FDA approval to market Vyvanse (lisdexamfetamine dimesylate), for the treatment of attention deficit hyperactivity disorder (ADHD). Vyvanse is a ...

Mission Prep has released a new guide for parents considering Vyvanse as a treatment for teens with ADHD. The document covers the medication’s mechanisms, clinical benefits, dosing protocols, side ...

ADHD is an acronym that stands for Attention Deficit Hyperactivity Disorder. It’s a condition that can affect a person’s ability to pay attention, stay focused, and control their impulses. Treatment ...

Attention deficit hyperactivity disorder (ADHD) and anxiety frequently coexist, especially in children. While they are distinct conditions, they often have overlapping symptoms. As a result, it can be ...

The U.S. Drug Enforcement Administration (DEA) has allowed an increase in Vyvanse production of around 24 percent to help with the ADHD drug shortage nationwide. The DEA greenlighted the spike in ...

Many children, teens, and young adults may be managing symptoms of both ADHD and anxiety at the same time. While medication is often an option, other strategies can be used to manage ADHD and anxiety ...

Alison Poulton is a director of the Australasian ADHD Professionals Association. She has previously taken part in an advisory panel and received personal fees and non-financial support from Takeda ...

One pharmaceutical manufacturer is recalling lots of generic Vyvanse over failed dissolution tests. Medication may not be working as it should.